WcW010: Telepresence Update

October 24, 2007

wcw1_thumb[1]

Web Conferencing Week

MUDGE’S Musings

Telepresence. An attractive concept for the Bentley and brie set, I guess. But, intriguing all the same (how the other .05% lives, an entire publishing industry has grown up around our fascination with how the [inordinately? unworthy?] rich spend their money and time).

From a trade publication titled Collaboration Loop: Collaborative Technologies in the Enterprise, comes a useful update to this topic covered in WcW004 some time ago.

collaborationloop

October 12, 2007
By Melanie Turek

ImageI recently got an update on Cisco’s telepresence initiative, and some of the facts are interesting. Clearly, there’s plenty of value in telepresence. At Frost & Sullivan, we expect the market to grow from $27.6 million to $610.5 million between 2006-2011, with a compound annual growth rate (GAGR) of 55.6%.

Not surprisingly, then, Cisco says telepresence is one of the fastest-selling products in the company’s history—Cisco has 50 new customers since introducing its telepresence systems 11months ago, and “huge” quarter-over-quarter growth, according to David Hsieh, Cisco’s CMO for Emerging Technologies. The company won’t report the number of sites per customer, but Hsieh says that most customers deploy two to five units initially, and that at least five customers initially deployed 10 units or more. Large customers are not hesitating to buy the product, he says, but the cost of bandwidth does determine deployments (and may explain why the majority of customers are US-based). “Seed, adopt, expand” is the typical deployment model.

I just must reprint (from Cisco by way of Computerworld, as printed in the original post) one of the illustrations, sadly lacking in this story, because of the all too true cliché that a picture is worth 22,473 (of MUDGE‘s) words.

telepresence

Who wouldn’t want to participate in such a conference? No travel time. No jet lag!

[Please click the link below for the complete article — but then please come on back!]

Collaboration Loop – Telepresence Case Studies: Real-World Applications (And, Is It Right for You?)

Wildly costly, now, but immensely, seductively attractive, if one can make those numbers work.

For the largest of companies, as the Wachovia example quoted, the numbers are not daunting.

Finally, look at the quoted anecdotal example of travel reduction:

On a personal note, UC VP and GM Rick McConnell says he’s cut his own travel by almost 40% thanks to the company’s telepresence solutions—going from 200,000 miles in 2006 to around 120,000 this year. He hopes to get that down “way below 100K” in 2008. (Which begs the question, is Cisco now competing with United Airlines et. al.? Hmmm…)

So, let me get this straight. I have two options. I can take the limo to the airport, fight through security even with my premium status, wait in the airline’s private lounge while my flight is delayed for the fourth time this month, etc. etc. etc.

Or, I can walk down the hall, engage my customer or colleagues two or twelve time zones away from the comfort of the new telepresence conference room, and be home to catch my daughter’s soccer championship that evening.

A paradigm changing technology, indeed!

It’s it for now. Thanks,

–MUDGE

Advertisements

mm176.5: Sleep: The Threequel

October 24, 2007

MUDGE’S Musings

Turns out that yesterday’s NYTimes didn’t stop at the two sleep stories we picked up yesterday. The obvious topic: pharmaceutical aids to sleep.

nytimes

By STEPHANIE SAUL

Your dreams miss you.

Or so says a television commercial for Rozerem, the sleeping pill. In the commercial, the dreams involve Abraham Lincoln, a beaver and a deep-sea diver.

Not the stuff most dreams are made of. But if the unusual pitch makes you want to try Rozerem, consider that it costs about $3.50 a pill; gets you to sleep 7 to 16 minutes faster than a placebo, or fake pill; and increases total sleep time 11 to 19 minutes, according to an analysis last year.

If those numbers send you out to buy another brand, consider this, as well: Sleeping pills in general do not greatly improve sleep for the average person.

Seen the Rozerem commercials. Kind of silly.

As a person with occasional sleep problems (staying asleep, rather than falling in the first place), I’ve consulted my physician and received over-the-counter advice, but no prescriptions.

Based on this story, that’s probably just as well.

[Please click the link below for the complete article — but then please come on back!]

Sleep Drugs Found Only Mildly Effective, but Wildly Popular – New York Times

At one time I worked with people who swore by a specific, popular sleep drug to beat jet lag. This was an international marketing research group, and its members were always on the go, with multiple-week business in Europe, mainly. Somehow, MUDGE never got invited. Oh, well.

Based on the incidence of reported odd side effects, like sleep-driving, I am happy enough not to need to indulge, for jet lag relief, or any other purpose.

I guess I’ll wait until they perfect them:

Still, researchers and drug companies have yet to find a holy grail. “The problem is, there is no ideal hypnotic,” said Dr. Manisha Witmans, a sleep medicine specialist at the University of Alberta’s Evidence-Based Practice Center. “The magic pill for sleep has not been invented yet.”

It’s it for now. Thanks,

–MUDGE